The pharma and biotech industry are dynamically developing and introducing new products for pharmaceuticals, medicinal products and nutritional supplements into the market. Often a demand for such new products arises in other countries, which are not in the primary business focus of the originators.
Glatt Engineering frequently receives inquiries to design and build production facilities for such new products. In such cases a product owner (pharmaceutical company) who is willing to offer a license and supporting tech transfer needs to be identified and committed.
The presentation provides an overview on the project development approach for this kind of projects which need to involve technology transfer and a licensing partner (licensor). Basic requirements and methods will be discussed; principles of the three-party project approach will be outlined and cornerstones for a TTA (technology transfer agreement) will be explained. Impact to project phases and schedule are considered along with necessary decisions, milestones and commitments to proceed with such complex projects successfully.